A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Pfizer
Pfizer
Hoffmann-La Roche
Pfizer
PharmaEngine
TG Therapeutics, Inc.
AbbVie
Amgen
Leaf Vertical Inc.
Hoffmann-La Roche
US Oncology Research
Pfizer
Mast Therapeutics, Inc.
Mast Therapeutics, Inc.